FindTrial
Sign In

The comparation of the range of parasternal plane block and transverse pectoral plane block

The comparation of the range of parasternal plane block and transverse pectoral plane block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083399
Enrollment
Unknown
Registered
2024-04-24
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular heart disease requiring midline thoracotomy

Interventions

Group P:Bilateral parasternal plane block with 0.375% ropivacaine 20ml
Group T:Bilateral transversus thoracis plane block with 0.375% ropivacaine 20ml

Sponsors

Wenzhou Medical University Affiliated First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 20-80 years; 2. With intact anterior chest skin sensation; 3. ASA class I-III ; 4.Patients scheduled for elective open heart surgery.

Exclusion criteria

Exclusion criteria: 1. BMI 30 kg/m2; 2. Impaired communication and comprehension; 3. History of allergy to local anaesthetics; 4. Spinal deformity, peripheral neuropathy and abnormal spinal cord function.

Design outcomes

Primary

MeasureTime frame
Area of sensory decline;Adverse reaction occurrence;—

Secondary

MeasureTime frame
The percentage of changes in blood pressure and heart rate during sternotomy;Intraoperative use of sufentanil;—

Countries

China

Contacts

Public ContactChen Hongfei

Wenzhou Medical University Affiliated First Hospital

chhfei@126.com+86 136 9580 2515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026